相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence and Risk Factors of Prolonged Corrected QT Interval Among Children and Adolescents Treated With Antipsychotic Medications A Long-Term Follow-Up in a Real-World Population
Inmaculada Palanca-Maresca et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
Trends in Antipsychotic Prescribing in Medicaid-Eligible Youth
Gail A. Edelsohn et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2017)
ADHD Treatment in Primary Care: Demographic Factors, Medication Trends, and Treatment Predictors
Tanya S. Hauck et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2017)
Interprovincial Variation in Antipsychotic and Antidepressant Prescriptions Dispensed in the Canadian Pediatric Population
Nikita Arora et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2016)
MULTIDISCIPLINARY HEALTHY LIVING PROGRAM IMPROVES METABOLIC SIDE EFFECTS ASSOCIATED WITH SECOND-GENERATION ANTIPSYCHOTICS IN CHILDREN AND YOUTH
Leah Wilson et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2016)
Sustained Use of Benzodiazepines and Escalation to High Doses in a Canadian Population
Silvia Alessi-Severini et al.
PSYCHIATRIC SERVICES (2016)
Child and Adolescent Psychiatrists' Reported Monitoring Behaviors for Second-Generation Antipsychotics
Angie Mae Rodday et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2015)
Metabolic Monitoring for Youths Initiating Use of Second-Generation Antipsychotics, 2003-2011
John G. Connolly et al.
PSYCHIATRIC SERVICES (2015)
Antipsychotic Cardiometabolic Side Effect Monitoring in a State Community Mental Health System
Robert O. Cotes et al.
COMMUNITY MENTAL HEALTH JOURNAL (2015)
The Role of Atypical Antipsychotics for Treatment of Tourette's Syndrome: An Overview
Cathy L. Budman
DRUGS (2014)
Adiposity Rebound and the Development of Metabolic Syndrome
Satomi Koyama et al.
PEDIATRICS (2014)
Comparative effectiveness of monotherapy with mood stabilizers versus second generation ( atypical) antipsychotics for the treatment of bipolar disorder in children and adolescents
Hua Chen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)
SENTIA: a systematic online monitoring registry for children and adolescents treated with antipsychotics
Inmaculada Palanca-Maresca et al.
SPRINGERPLUS (2014)
The effect of atypical antipsychotic medications in individuals with anorexia nervosa: A systematic review and meta-analysis
Jocelyn Lebow et al.
INTERNATIONAL JOURNAL OF EATING DISORDERS (2013)
Weight Gain and Other Metabolic Adverse Effects Associated with Atypical Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-analysis
Noor B. Almandil et al.
PEDIATRIC DRUGS (2013)
Lessons Learned From a Colocation Model Using Psychiatrists in Urban Primary Care Settings
Meredith Weiss et al.
JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH (2013)
Metabolic Screening in Children Receiving Antipsychotic Drug Treatment
Elaine H. Morrato et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2012)
Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices
A. J. Mitchell et al.
PSYCHOLOGICAL MEDICINE (2012)
Metabolic and Neurological Complications of Second-Generation Antipsychotic Use in Children A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Tamara Pringsheim et al.
DRUG SAFETY (2011)
Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice
M. De Hert et al.
EUROPEAN PSYCHIATRY (2011)
The Pharmacoepidemiology of Antipsychotic Medications for Canadian Children and Adolescents: 2005-2009
Tamara Pringsheim et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2011)
Weight Gain and Metabolic Risks Associated with Antipsychotic Medications in Children and Adolescents
Lawrence Maayan et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2011)
Olanzapine versus placebo for out-patients with anorexia nervosa
E. Attia et al.
PSYCHOLOGICAL MEDICINE (2011)
Antipsychotic drugs and obesity
Christoph U. Correll et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Atypical Antipsychotics for Acute Manic and Mixed Episodes in Children and Adolescents with Bipolar Disorder Efficacy and Tolerability
Manpreet K. Singh et al.
DRUGS (2010)
Management of antipsychotic-related weight gain
Lawrence Maayan et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Prevalence and Predictors of Lipid and Glucose Monitoring in Commercially Insured Patients Treated With Second-Generation Antipsychotic Agents
Dan W. Haupt et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration
Lizheng Shi et al.
BMC PSYCHIATRY (2009)
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
Christoph U. Correll et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder
Randall Owen et al.
PEDIATRICS (2009)
Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder
Wan Seok Seo et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2008)
Quetiapine addition in methylphenidate treatment-resistant adolescents with comorbid attention-deficit/hyperactivity disorder, conduct/oppositional-defiant disorder, and aggression: A prospective, open-label study
William G. Kronenberger et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2007)
Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents
Christoph U. Correll et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2006)
Consensus development conference on antipsychotic drugs and obesity and diabetes
DIABETES CARE (2004)
Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ
MG Aman et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2004)
Risperidone in children with autism and serious behavioral problems
JT McCracken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Weight gain associated with olanzapine and risperidone in adolescent patients: A comparative prospective study
G Ratzoni et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2002)
分享论文
